Correlation of Vascular Endothelial Growth Factor Levels in Anterior Chamber Fluid to Disease State in Patients With Retinal Vein Occlusion Receiving Standard of Care Treatment
Latest Information Update: 26 Mar 2024
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinal oedema; Retinal vein occlusion
- Focus Therapeutic Use
- 20 Mar 2024 Status changed from suspended to discontinued. IRB stopped study due to safety concerns. No further data collection and what has been collected is not appropriate for analysis.
- 08 Dec 2023 Planned End Date changed from 1 Feb 2024 to 1 Aug 2024.
- 08 Dec 2023 Planned primary completion date changed from 1 Dec 2023 to 1 Jun 2024.